MassMutual Private Wealth & Trust’s Cryo-Cell International CCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$354K Hold
111,035
0.01% 360
2026
Q1
$394K Hold
111,035
0.01% 334
2025
Q4
$382K Hold
111,035
0.01% 342
2025
Q3
$515K Hold
111,035
0.01% 315
2025
Q2
$576K Hold
111,035
0.02% 302
2025
Q1
$707K Hold
111,035
0.02% 284
2024
Q4
$823K Hold
111,035
0.02% 264
2024
Q3
$707K Hold
111,035
0.02% 274
2024
Q2
$845K Hold
111,035
0.03% 249
2024
Q1
$828K Sell
111,035
-3,178
-3% -$18K 0.03% 249
2023
Q4
$657K Sell
114,213
-9,922
-8% -$51.4K 0.02% 259
2023
Q3
$653K Hold
124,135
0.02% 260
2023
Q2
$755K Hold
124,135
0.03% 240
2023
Q1
$375K Hold
124,135
0.01% 299
2022
Q4
$525K Hold
124,135
0.02% 269
2022
Q3
$757K Hold
124,135
0.03% 239
2022
Q2
$732K Buy
124,135
+48,100
+63% +$308K 0.03% 241
2022
Q1
$580K Hold
76,035
0.02% 265
2021
Q4
$882K Hold
76,035
0.03% 250
2021
Q3
$921K Buy
+76,035
New +$937K 0.04% 234

MassMutual Private Wealth & Trust's CCEL Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Cryo-Cell International (CCEL) position steady in Q2 2026 at 111,035 shares worth $354K. The position accounts for 0.01% of the portfolio, ranked #360.

MassMutual Private Wealth & Trust first reported a position in CCEL in Q3 2021 and has held it in 20 quarters since. The position peaked at $921K in Q3 2021. 1 fund tracked by Wall St. Rank holds CCEL as of Q2 2026.

  • MassMutual Private Wealth & Trust held 111,035 shares of Cryo-Cell International worth $354K as of Q2 2026.
  • MassMutual Private Wealth & Trust left its Cryo-Cell International share count unchanged in Q2 2026.
  • Cryo-Cell International made up 0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #360 holding.
  • MassMutual Private Wealth & Trust first reported a position in Cryo-Cell International in Q3 2021 and has held it in 20 quarters since.
  • MassMutual Private Wealth & Trust's Cryo-Cell International position peaked at $921K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Cryo-Cell International as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.